Top Markets
#1 Islamic Coin Islamic Coin +152.23%
#2 Bitway Bitway +48.15%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +38.47%
#4 Starpower Starpower +34.30%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.46%
#6 Pons Pons +21.04%
#7 aelf aelf +19.67%
#8 Pleasing Gold Pleasing Gold +17.80%
#9 Venom Venom +14.89%
#10 Decred Decred +14.18%
Coin of the day
Islamic Coin Islamic Coin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Perseus Proteomics Inc. Perseus Proteomics Inc.

Perseus Proteomics Inc.

4882
Rang in aandelen #30379
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology... Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.
Aandeelprijs
$0.91993619
Marktkapitalisatie
$16.95M
Verandering (1 dag)
-2.76%
Verandering (1 jaar)
-63.00%
Land
JP
Handel Perseus Proteomics Inc. (4882)

Categorie

Healthcare
Aandelsplitsingen voor Perseus Proteomics Inc. (4882)
Het aandeel Perseus Proteomics Inc. (symbool: 4882) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 19, 2026.
Eén aandeel 4882 dat vóór Aug 19, 2026 werd gekocht, staat nu gelijk aan 0 aandelen 4882.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 4 x15
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7 x432
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 2 x10000
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US